의약품 품질 관리 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Pharmaceutical Quality Control Market is presumed to reach the market size of nearly USD 34.3 Billion by 2032 from USD 11.29 Billion in 2023 with a CAGR of 13.14% under the study period 2024 - 2032.

Pharmaceutical quality control involves a series of processes and procedures to ensure that pharmaceutical products meet predefined quality standards and regulatory requirements. This includes testing raw materials, in-process samples, and finished products for identity, purity, potency, and safety. Quality control measures in the pharmaceutical industry are essential to ensure the efficacy and safety of medications, prevent defects, and comply with regulatory guidelines, ensuring that pharmaceutical products consistently meet the expected quality standards.

MARKET DYNAMICS

The pharmaceutical quality control market is propelled by the rigorous regulatory standards within the pharmaceutical sector and a heightened focus on guaranteeing the safety and effectiveness of pharmaceutical products. The escalating intricacy of pharmaceutical formulations, the imperative to adhere to Good Manufacturing Practices, and the upsurge in counterfeit drugs collectively drive the need for sophisticated quality control solutions. Advanced analytical techniques, including chromatography, spectroscopy, and mass spectrometry, play a pivotal role in ensuring the quality of pharmaceutical products. The increasing focus on research and development, technological advancements in analytical instruments, and the globalization of pharmaceutical supply chains further stimulate the growth of the pharmaceutical quality control market. Ensuring product quality and regulatory compliance remains a top priority for pharmaceutical companies, driving continuous innovation and investment in quality control processes and technologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical quality control. The growth and trends of pharmaceutical quality control industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical quality control market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Consumables
• Services
• Instruments

By Analysis Type

• Sterility Testing
• Raw Material Testing
• Bioburden Testing
• Extractable & Leachable Testing
• Endotoxin Testing
• Raw Material Testing

By Product Tested

• Vaccines
• Drugs
• Plasma Products

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Quality Control market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

• GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
• Global Pharmaceutical Quality Control Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Quality Control market include Wixi Apptec, Biomerieux SA, Merck Kgaa, Thermo Fisher Scientific Inc., Remi Group, Perkin Elmer, Shimadzu Scientific Instruments, Esco Micro Pte. Ltd., Charles River Laboratories International Inc., Danaher Corporation, Mettler Toledo, Waters Corporation, Toxikon Corporation, Lucideon Limited, Sartorius AG, Bram-Cor Spa, SGS S.A., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PHARMACEUTICAL QUALITY CONTROL - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Analysis Type
  • 3.7.3 Market Attractiveness Analysis By Product Tested
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Consumables Historic and Forecast Sales by Regions
• 5.5 Services Historic and Forecast Sales by Regions
• 5.6 Instruments Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET ANALYSIS BY ANALYSIS TYPE

• 6.1 Overview by Analysis Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Analysis Type
• 6.4 Sterility Testing Historic and Forecast Sales by Regions
• 6.5 Raw Material Testing Historic and Forecast Sales by Regions
• 6.6 Bioburden Testing Historic and Forecast Sales by Regions
• 6.7 Extractable & Leachable Testing Historic and Forecast Sales by Regions
• 6.8 Endotoxin Testing Historic and Forecast Sales by Regions
• 6.9 Raw Material Testing Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET ANALYSIS BY PRODUCT TESTED

• 7.1 Overview by Product Tested
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Product Tested
• 7.4 Vaccines Historic and Forecast Sales by Regions
• 7.5 Drugs Historic and Forecast Sales by Regions
• 7.6 Plasma Products Historic and Forecast Sales by Regions

8 . GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL QUALITY CONTROL COMPANIES

• 9.1. Pharmaceutical Quality Control Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF PHARMACEUTICAL QUALITY CONTROL INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Wixi Apptec
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Biomerieux SA
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Merck Kgaa
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Thermo Fisher Scientific Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Remi Group
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Perkin Elmer
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Shimadzu Scientific Instruments
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Esco Micro Pte. Ltd.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Charles River Laboratories International Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Danaher Corporation
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Mettler Toledo
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Waters Corporation
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Toxikon Corporation
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. Lucideon Limited
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments
• 10.17. Sartorius AG
  • 10.17.1. Company Overview
  • 10.17.2. Company Revenue
  • 10.17.3. Products
  • 10.17.4. Recent Developments
• 10.18. Bram-Cor Spa
  • 10.18.1. Company Overview
  • 10.18.2. Company Revenue
  • 10.18.3. Products
  • 10.18.4. Recent Developments
• 10.19. SGS S.A.
  • 10.19.1. Company Overview
  • 10.19.2. Company Revenue
  • 10.19.3. Products
  • 10.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies